Dr. Wiggin W. Lee, MD

Dr. Lee practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Lee's NPI, 1811239064, was assigned on March 25, 2013. Dr. Lee graduated from University of California, San Diego School of Medicine in 2013. Dr. Lee holds California license A134789.

Dr. Lee's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Lee's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Lee to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Lee is board certified in dermatology by the American Board of Dermatology. Dr. Lee is licensed in California.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, itchy rashes, psoriasis, rash and scalp rash among the conditions Dr. Lee treats.

CMS data shows 706 Medicare services from Dr. Lee across 12 procedure codes in 2024, for 138 Medicare patients. Medicare paid $33,502 for them. Every service was in an office.

CMS counts 138 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 88 patients. 64% of them have high cholesterol, and 47% have high blood pressure. Their average risk score is 0.73, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 62, with 56% women.

In 2024, Dr. Lee wrote 282 Medicare Part D claims for 163 patients. 96% of them were for generic drugs. CMS names the drug for 204 of them, across 7 drugs with 11 or more claims each, at $7,364 in total drug cost. In 2023, CMS named 105 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lee for performance year 2024, reported as part of a group. Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth. CMS counts 253 procedures of removal of skin lesions by Dr. Lee, more than 81% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Lee in 2016. Dr. Lee's most frequent co-authors are Taraneh Paravar, MD and Tina Neda Vajdi, MD.

CMS Open Payments shows 107 general payments to Dr. Lee from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $907.

Dr. Lee graduated from University of California, San Diego School of Medicine in 2013.

Dr. Lee is in network with 6 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.